Position history for VANGUARD GROUP INC's holdings in BIOCRYST PHARMACEUTICALS INC
VANGUARD GROUP INC holds 22.3M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $173.7M as of 2025-Q4. The position was increased (+2.2% shares). BCRX represents 0.0% of VANGUARD GROUP INC's portfolio.
Current Value
$173.7M
Current Shares
22.3M
Total Value Change
+$19.4M
Total Shares Change
+2M
Other major holders of BCRX: BlackRock, Inc., BAKER BROS. ADVISORS LP
Increased |
| 22.3M |
+2.2% |
| $173.7M |
| 0.0% |
| $7.66 |
31 |
| 2025-Q3 | Increased | 21.8M | +6.1% | $165.4M | 0.0% | $7.55 | 32 |
| 2025-Q2 | Decreased | 20.5M | -5.2% | $184.1M | 0.0% | $9.36 | 0 |
| 2025-Q1 | Decreased | 21.7M | -1.1% | $162.4M | 0.0% | $7.86 | 0 |
| 2024-Q4 | Increased | 21.9M | +7.8% | $164.6M | 0.0% | $7.53 | 33 |
| 2024-Q3 | New | 20.3M | - | $154.3M | 0.0% | $7.62 | 42 |